YKYulia V. Kargina

Yulia V. Kargina

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yulia V. Kargina has a total of 59 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Laser-Ablative Synthesis of Silicon–Iron Composite Nanoparticles for Theranostic Applications

    by Alexander A. Bubnov, Vladimir S. Belov, Yulia V. Kargina, Gleb V. Tikhonowski, Anton A. Popov, Alexander Yu. Kharin, Mikhail V. Shestakov, Alexander M. Perepukhov, Alexander V. Syuy, Valentyn S. Volkov, et al.

    The combination of photothermal and magnetic functionalities in one biocompatible nanoformulation forms an attractive basis for developing multifunctional agents for biomedical theranostics. Here, we report the fabrication of silicon–iron (Si-Fe) composite nanoparticles (NPs) for theranostic applications by using a method of femtosecond laser ablation in acetone from a mixed target combining silicon and iron. The NPs were then transferred to water for subsequent biological use. From structural analyses, it was shown that the formed Si-Fe NPs have a spherical shape and sizes ranging from 5 to 150 nm, with the presence of two characteristic maxima around 20 nm and 90 nm in the size distribution. They are mostly composed of silicon with the presence of a significant iron silicide content and iron oxide inclusions. Our studies also show that the NPs exhibit magnetic properties due to the presence of iron ions in their composition, which makes the formation of contrast in magnetic resonance imaging (MRI) possible, as it is verified by magnetic resonance relaxometry at the proton resonance frequency. In addition, the Si-Fe NPs are characterized by strong optical absorption in the window of relative transparency of bio-tissue (650–950 nm). Benefiting from such absorption, the Si-Fe NPs provide strong photoheating in their aqueous suspensions under continuous wave laser excitation at 808 nm. The NP-induced photoheating is described by a photothermal conversion efficiency of 33–42%, which is approximately 3.0–3.3 times larger than that for pure laser-synthesized Si NPs, and it is explained by the presence of iron silicide in the NP composition. Combining the strong photothermal effect and MRI functionality, the synthesized Si-Fe NPs promise a major advancement of modalities for cancer theranostics, including MRI-guided photothermal therapy and surgery.


  • Composite silicon-iron nanoparticles: physical properties and potential application in MRI contrasting

    by Yulia V. Kargina, Alexey V. Sobolev, Ekaterina S. Kozlyakova, Alexander N. Vasiliev, Alexander Yu. Kharin, Nina V. Sharonova, Alexander M. Perepukhov, Anna V. Stavitskaya, Anatoly A. Ischenko, Victor Yu. Timoshenko


  • Open Access

    Proton magnetization relaxation in aqueous suspensions of composite silicon-iron nanoparticles for biomedical applications

    by Yu V Kargina, A D Mironova, A Yu Kharin, A M Perepukhov, A A Ischenko, V Yu Timoshenko

    Silicon-iron composite nanoparticles produced by arc-discharge plasma ablation method were characterized by scanning electron microscopy, dynamic light scattering, X-ray fluorescence diffractometry, and the effect of iron content and size of the nanoparticles on hydrogen nuclei magnetization relaxation were investigated by nuclear magnetic resonance relaxometry. It was shown that increasing in iron content during the synthesis leads to distortion of the spherical shape of the nanoparticles and increasing of their mean sizes from 140 nm to 350 nm. Nonlinear dependence of the longitudinal and transverse relaxivities from iron content was demonstrated. Increase in the iron concentration above 2.5 at. % leads to reduction of the both relaxivities, which can be explained by nonuniform distribution of iron and formation of iron containing agglomerates. It was shown that transverse and longitudinal relaxivities of the nanoparticles in their aqueous solutions inversely proportional from their hydrodynamic diameters in the range of 100 – 300 nm. The possibilities of using composite silicon-iron nanoparticles for biomedical applications are discussed.

  • Silicon nanoparticles with iron impurities for multifunctional applications

    by Yu. V. Kargina, S. V. Zinovyev, A. M. Perepukhov, E. V. Suslova, A. A. Ischenko, V. Yu. Timoshenko


  • Silicon Nanoparticles Prepared by Plasma‐Assisted Ablative Synthesis: Physical Properties and Potential Biomedical Applications

    by Yulia V. Kargina, Aleksandr M. Perepukhov, Aleksandr Yu. Kharin, Elena A. Zvereva, Anatolii V. Koshelev, Sergei V. Zinovyev, Aleksandr V. Maximychev, Alida F. Alykova, Nina V. Sharonova, Vitalii P. Zubov, et al.

    Silicon (Si) nanoparticles (NPs) with small (10−3–10−1 at%) content of iron oxide (Fe2O3) are prepared by plasma‐assisted ablative synthesis. Powders of the prepared Si‐iron oxide (SIO) NPs are investigated by means of the transmission electron microscopy, Raman spectroscopy, electron paramagnetic resonance, and magnetic susceptibility measurements. Aqueous suspensions of the NPs are studied by using dynamic light scattering and nuclear magnetic resonance technique. The longitudinal and transverse relaxation times of protons in aqueous suspensions of the NPs are found to be dependent on the iron content. The stronger decrease of the proton relaxation is detected for the samples with higher iron content. Magnetic resonance imaging (MRI) experiments show that SIO NPs have properties of the MRI contrast agent and it is confirmed by in vivo experiments with cancer tumor. Aqueous suspensions of SIO NPs are explored as sensitizers of electromagnetic radio frequency hyperthermia and the highest heating rate is observed for the NPs with smaller hydrodynamic size (≈50 nm). The obtained results indicate possible ways for applications of SIO NPs in the MRI diagnostics and mild therapy of cancer.


  • Investigation of proton spin relaxation in water with dispersed silicon nanoparticles for potential magnetic resonance imaging applications

    by Yu. V. Kargina, M. B. Gongalsky, A. M. Perepukhov, A. A. Gippius, A. A. Minnekhanov, E. A. Zvereva, A. V. Maximychev, V. Yu. Timoshenko

    Porous and nonporous silicon (Si) nanoparticles (NPs) prepared by ball-milling of electrochemically etched porous Si layers and crystalline Si wafers were studied as potential agents for enhancement of the proton spin relaxation in aqueous media. While nonporous Si NPs did not significantly influence the spin relaxation, the porous ones resulted in strong shortening of the transverse relaxation times. In order to investigate an effect of the electron spin density in porous Si NPs on the proton spin relaxation, we use thermal annealing of the NPs in vacuum or in air. The transverse relaxation rate of about 0.5 l/(g s) was achieved for microporous Si NPs, which were thermally annealing in vacuum to obtain the electron spin density of the order of 1017 g−1. The transverse relaxation rate was found to be almost proportional to the concentration of porous Si NPs in the range from 0.1 to 20 g/l. The obtained results are discussed in view of possible biomedical applications of Si NPs as contrast agents for magnetic resonance imaging.


  • Silicon Nanoparticles as Amplifiers of the Ultrasonic Effect in Sonodynamic Therapy

    by L. A. Osminkina, A. A. Kudryavtsev, S. V. Zinovyev, A. P. Sviridov, Yu. V. Kargina, K. P. Tamarov, V. N. Nikiforov, A. V. Ivanov, A. N. Vasilyev, V. Yu. Timoshenko

    The possibility of using mesoporous silicon nanoparticles as amplifiers (sensitizers) of therapeutic ultrasonic exposure were studied experimentally in vitro and in vivo. The combination of nanoparticles and ultrasound led to a significant inhibition of Hep-2 cancer cell proliferation and Lewis lung carcinoma growth in mice. These results indicated good prospects of using silicon nanoparticles as sensitizers for sonodynamic therapy of tumors.